Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc > Food for thought
View:
Post by GObabyGO1 on May 09, 2020 3:53pm

Food for thought

Taking a look at the Algernon website today. Found an interesting figure they posted from the PhRMA about trial success rates. 55% of phase ll trials succeed and 33% of successful phase ll drugs are approved. Take from that what you want.
Comment by Laliberte2020 on May 09, 2020 4:55pm
If I recall one of the last interview, Chris said that of the ~50% trials that fail, half of them are for safety reasons. This is where to concept of repurposing is an advantage for us since we know the drug is safe and used for almost 50yrs. Glta
Comment by Pandora on May 09, 2020 5:38pm
Yeah, that's like hydroxychloroquine and look at all the rigamarole that is going through -- but most of that is associated with Trump saying it was good and safe -- then 60% of the population automatically rejected it - even after 50 years of safe use. AGN and Ifenprodil are at least safe from that scourge.
Comment by theNorm on May 09, 2020 6:37pm
I put Ifenprodil's possibility of success at greater than 90%  Most of the research being done globally seeks to stop the cytokine storm that damages the lungs.  Ifenprodil has shown an ability to stop the storm and prevent lung degeneration & scarring.  IMO if administered in time, it will save lives by turning the course of the infection and keeping patients from having to ...more  
Comment by luvhorses on May 09, 2020 8:06pm
It's all about keeping the LUNGS safe!!! You don't need to have the C19 virus to know about the lungs!!!  It's just like when you have the common cold....you feel terrible because your lungs are plugged up with phelgm!!   So, with the C19 virus, you can only imagine just how bad the lungs are..all  of that coughing and wheezing! Now, I'm not a doctor, but I ...more  
Comment by luvhorses on May 09, 2020 8:01pm
And remember, Pandora, you forgot Trump's famous words @ the time: "I'm not a  doctor but I have common sense." Are  you  funken kiddin' me?  Well, let's see how much  common sense he has in the next few weeks as he really ought to be going in to quarantine since his valet driver was tested positive for the C19 virus!!! $hit, you gotta luv the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities